Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | ADXS-NEO |
Synonyms | |
Therapy Description |
ADXS-NEO is a Listeria monocytogenes-based plasmid vaccine that contains a truncated form of listeriolysin O fused to patient-specific immunogenic neoepitopes, potentially resulting in a personalized immunogenic response and antitumor efficacy (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
ADXS-NEO | ADXS NEO | ADXS-NEO is a Listeria monocytogenes-based plasmid vaccine that contains a truncated form of listeriolysin O fused to patient-specific immunogenic neoepitopes, potentially resulting in a personalized immunogenic response and antitumor efficacy (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03265080 | Phase I | ADXS-NEO | Expressing Personalized Tumor Antigens Study | Terminated | USA | 0 |